Efficacy and safety of RevoLix 2 micron continuous wave laser vaporesection in treatment for senile patients with benign prostatic hyperplasia

VernacularTitle:高龄前列腺增生患者行经尿道2 μm激光气化切除术的疗效与安全性
Author: Jianlong WANG ; Leilei WANG ; Ming LIU ; Pengjie WU ; Yaoguang ZHANG ; Ben WAN ; Jianye WANG
Keywords: Lasers therapy; Prostatic hyperplasia; Transurethral resection of prostate
From: Chinese Journal of General Practitioners 2017;16(7):551-553
CountryChina
Language:Chinese
Abstract: The clinical efficacy and safety of RevoLix 2 μm continuous wave laser vaporesection in treatment of senile patients with benign prostatic hyperplasia (BPH) were retrospective evaluated.In 291 senile patients with BPH,213 received 2 μm continuous wave laser vaporesection (group A) and other 78 patients received transurethral resection of prostate (TURP, group B).Compared with group B the intraoperative blood loss was less, the bladder irrigation time, catheter time and hospitalization time were shorter in group A.The subjective or objective indexes were all significantly improved at 3 and 12 months after laser treatment.The improvements of international prostate symptom score (IPSS), IPSS-S, overactive bladder symptom score (OABSS) in patients of 70-79 were more marked than those of 80 or older.Patients with mild overactive bladder (OAB) had less improvement in IPSS and IPSS-S than those with moderate-severe OAB which suggest that the storage symptoms could be improved significantly by removing obstruction.